<?xml version="1.0" encoding="UTF-8"?>
<results title="eoPlant">
 <result pre="of 1) the absence, in the detailed sheet, of pharmaceutical-grade" exact="Cannabis sativa" post="varieties; 2) the use of pharmaceutical-grade Cannabis sativa varieties"/>
 <result pre="of pharmaceutical-grade Cannabis sativa varieties; 2) the use of pharmaceutical-grade" exact="Cannabis sativa" post="varieties diverse from Bedrocan, Bediol, Bedrolite, and FM2; and"/>
 <result pre="was divided by preparation methods (Figure 1C) and varieties of" exact="Cannabis sativa" post="(Figure 1D). The subpopulation sampled maintains the same distribution"/>
 <result pre="CBD (0.04 Â± 0.31). FIGURE 3 Distribution of phytocannabinoids among" exact="Cannabis sativa" post="varieties (4,774, mean Â± SD). In the different cannabis"/>
 <result pre="Pharmacol.10, 1â€&quot;10. 10.3389/fphar.2019.0070130728774 BettiolA.LombardiN.CrescioliG.MagginiV.GalloE.MugelliA.et al. (2019). Galenic preparations of therapeutic" exact="Cannabis sativa" post="differ in cannabinoids concentration: a quantitative analysis of variability"/>
 <result pre="Plus56, 23710.3390/medicina56050237 CalviL.PentimalliD.PanseriS.GiupponiL.GelminiF.BerettaG.et al. (2018). Comprehensive quality evaluation of medical" exact="Cannabis sativa" post="L. inflorescence and macerated oils based on HS-SPME coupled"/>
</results>
